FundedIQ
Health Care

Remedee Labs: Funding, Investors & Team (Sep 2026)

Remedee Labs aims to change people’s lives thanks to a patient-centric digital service platform using the first endorphin stimulator. 1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life. Based on 10 years of pre-clinical and clinical research, Remedee Labs has developed the first endorphin stimulator for personal use. Building on the experience of its clinical partners, the company now uses its unique technology to offer the first patient-centered digital service platform for chronic pain management, working alongside medical practitioners.

www.remedeelabs.com LinkedIn Montbonnot-saint-martin, France 11-50 employees
Health Care Medical Device B2B B2C
Total raised
$12.8M
Rounds
1
Latest
Series A
Dec 2022

Remedee Labs has raised $12.8M across 1 funding round on record, the most recent a Series A of $12.8M announced in Dec 2022.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Remedee Labs Company Profile and Key Stats

Total funding raised
$12.8M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$12.8M in Dec 2022
Employees
11-50
reported band
Headquarters
Montbonnot-saint-martin, France

Latest funding round on record: Dec 2022.

Remedee Labs Funding Rounds

Date
Round
Amount
Series A
$12.8M

Remedee Labs Founders and Leadership Team

Name
Role
Contact
Jacques Husser
Founder

No contact details are on record for this team yet.

Remedee Labs Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
1,705
$6.7M
8,352
$15M

Remedee Labs' latest round of $12.8M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Remedee Labs in Health Care and Montbonnot-saint-martin

Companies Similar to Remedee Labs

Beams is a producer of medical devices for cancerology based on the use of particles β.

Undisclosed round $1.7M

Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…

Undisclosed round

CILcare specializes in providing drug solutions for hearing and ear disorders.

Undisclosed round

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…

Undisclosed round $58.1M

noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…

Seed $5.8M

Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…

Undisclosed round $24.7M

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the…

Seed $13.0M

Axomove is an e-wellbeing application that spends significant time in video actual activities.

Series A $4.7M

Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…

Series A $20.0M

May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…

Undisclosed round $11.6M

MedinCell is an injectable slow-release drug specialist company.

Undisclosed round $55.7M

Charles helps men regain control over their daily health concerns by starting with their personal health.

Undisclosed round $300k

Remedee Labs Funding FAQs

What does Remedee Labs do?

Remedee Labs aims to change people’s lives thanks to a patient-centric digital service platform using the first endorphin stimulator. 1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life. Based on 10 years of pre-clinical and clinical research, Remedee Labs has developed the first endorphin stimulator for personal use. Building on the experience of its clinical partners, the company now uses its unique technology to offer the first patient-centered digital service platform for chronic pain management, working alongside medical practitioners.

How much funding has Remedee Labs raised?

Remedee Labs has raised $12.8M across 1 round on record. The most recent is a Series A of $12.8M announced in Dec 2022.

When did Remedee Labs last raise funding?

Remedee Labs' most recent funding round on record is a Series A of $12.8M, announced in Dec 2022.

Who founded Remedee Labs?

FundedIQ lists Jacques Husser (Founder) at Remedee Labs.

Where is Remedee Labs headquartered?

Remedee Labs is based in Montbonnot-saint-martin, Rhone-Alpes, France.

How many employees does Remedee Labs have?

Remedee Labs is in the 11-50 employee band.

How does Remedee Labs' funding compare to other Health Care startups?

Remedee Labs' latest round of $12.8M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Remedee Labs Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Remedee Labs is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.